Cargando…
An automated controlled-release device for intravaginal hormone delivery
Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regressio...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623694/ https://www.ncbi.nlm.nih.gov/pubmed/36340429 http://dx.doi.org/10.3168/jdsc.2020-18816 |
_version_ | 1784822060181094400 |
---|---|
author | Masello, M. Ren, Y. Erickson, D. Giordano, J.O. |
author_facet | Masello, M. Ren, Y. Erickson, D. Giordano, J.O. |
author_sort | Masello, M. |
collection | PubMed |
description | Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF(2α). The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = −0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum ≥15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF(2α) 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF(2α) released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF(2α) for successful induction of luteal regression in lactating dairy cows. |
format | Online Article Text |
id | pubmed-9623694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96236942022-11-04 An automated controlled-release device for intravaginal hormone delivery Masello, M. Ren, Y. Erickson, D. Giordano, J.O. JDS Commun Research Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF(2α). The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = −0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum ≥15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF(2α) 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF(2α) released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF(2α) for successful induction of luteal regression in lactating dairy cows. Elsevier 2020-09-02 /pmc/articles/PMC9623694/ /pubmed/36340429 http://dx.doi.org/10.3168/jdsc.2020-18816 Text en © 2020. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Masello, M. Ren, Y. Erickson, D. Giordano, J.O. An automated controlled-release device for intravaginal hormone delivery |
title | An automated controlled-release device for intravaginal hormone delivery |
title_full | An automated controlled-release device for intravaginal hormone delivery |
title_fullStr | An automated controlled-release device for intravaginal hormone delivery |
title_full_unstemmed | An automated controlled-release device for intravaginal hormone delivery |
title_short | An automated controlled-release device for intravaginal hormone delivery |
title_sort | automated controlled-release device for intravaginal hormone delivery |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623694/ https://www.ncbi.nlm.nih.gov/pubmed/36340429 http://dx.doi.org/10.3168/jdsc.2020-18816 |
work_keys_str_mv | AT masellom anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery AT reny anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery AT ericksond anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery AT giordanojo anautomatedcontrolledreleasedeviceforintravaginalhormonedelivery AT masellom automatedcontrolledreleasedeviceforintravaginalhormonedelivery AT reny automatedcontrolledreleasedeviceforintravaginalhormonedelivery AT ericksond automatedcontrolledreleasedeviceforintravaginalhormonedelivery AT giordanojo automatedcontrolledreleasedeviceforintravaginalhormonedelivery |